The U.S. medical-device industry continues to "enjoy a positive balance of trade," in which more products are exported than imported, said Brett Loper, AdvaMed's chief lobbyist. However, the health reform law's industry taxes and the slow pace of regulatory process could force medical device firms to move manufacturing operations to Europe, according to industry representatives.

Related Summaries